Insiders GeneDx Holdings Corp.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			After market 06:18:48 pm
11 ^USD	-0.72%		14.2	+29.09%

Apr. 23	Genedx Announces Partnership with Komodo Health to Expand Access to World?S Largest Rare Disease Dataset	CI
Apr. 15	Goldman Sachs Adjusts GeneDx Holdings Price Target to $11 From $6, Maintains Neutral Rating	MT

Genedx Holdings Insider Bought Shares Worth $161,368, According to a Recent SEC Filing	Nov. 20	MT
Genedx Holdings Insider Sold Shares Worth $1,140,027, According to a Recent SEC Filing	Nov. 17	MT
Genedx Holdings Corp. Announces Executive Appointments	23-09-11	CI
GeneDx Holdings Corp. Announces Rachel Sherman and Dennis Charney Notifies the Board That They Will Not Stand for Re-Election as Directors	23-04-28	CI
GeneDx Appoints Devin K. Schaffer as General Counsel, Effective April 24, 2023	23-04-03	CI
GeneDx Holdings Corp. Announces Resignation of Michael Pellini from the Board of Directors	23-02-14	CI
Insider Buy: Genedx Holdings	23-02-02	MT
Sema4 Holdings Corp has Changed its Name to GeneDx Holdings Corp	23-01-09	CI
Insider Sell: Sema4 Holdings	22-12-05	MT
Sema4 Holdings Names Kevin Feeley as CFO	22-08-26	MT
Sema4 Announces Executive Changes	22-08-15	CI
Sema4 Holdings Corp. Announces Executive Changes	22-07-01	CI
Sema4 Chief Financial Officer Isaac Ro to Depart in August	22-06-14	MT
Insider Buy: Sema4 Holdings	22-05-03	MT
Insider Buy: Sema4 Holdings	22-05-03	MT
Sema4 Announces Management Changes	22-05-02	CI
Sema4 Appoints Katherine Stueland as CEO	22-05-02	CI
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022	22-03-08	AQ
Sema4 Appoints Jerry Conway as Senior Vice President	22-02-01	CI
James Coffin to Leave Sema4 Holdings Corp. as President, and Chief Operating Officer	22-01-31	CI

No results for this search